Provider review
Injectco review
One charge for a supply the seller says lasts somewhere between six and eight months.
The per-month figure printed beside it is that block divided at its most optimistic end, and offered as a payment plan.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Injectco
$1,249 for a supply the seller calls 6 to 8 months at the starting dose
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Quotes off the lowest dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The pricing here is a single charge for a block of medication, and the block does not have a fixed length. The seller says the supply runs six to eight months at the starting dose, which spreads the same money across a range wide enough that the monthly cost differs by a third depending on which end holds. That is not evasive so much as honest about something most sellers hide: a vial lasts as long as the dose lets it, and a company selling by the vial rather than by the month cannot promise a monthly figure without knowing what you will take. For this site's reader that structure is unusually favorable, because it is the only arrangement in which taking less genuinely buys more time rather than simply wasting drug. Someone holding the starting dose reaches the long end of the range; someone titrating upward reaches the short end. The number to be careful with is the one printed beside the block price. It is the block divided by the most optimistic supply length, and the page presents it as a payment plan, which is a financing arrangement rather than a rate for medication. Anyone budgeting from it is assuming the best case on a range the seller declines to narrow. The larger gap is that no drug is named at any point. The product is described by its class, the questions and answers discuss peptide therapy in general, and the only manufacturers mentioned appear in a disclaimer distancing the company from them.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You intend to hold the starting dose, which is what stretches the block to its long end
- You would rather pay once for a long supply than carry a recurring monthly charge
- You want the consult, the prescription and delivery inside one charge with no membership
Look elsewhere if
- You need a monthly figure to compare. The supply length is a range the seller will not narrow
- You expect to titrate upward, which exhausts the same charge months sooner
- You want to know which drug you are buying. None is named anywhere on the page
What it actually costs
Price as published
No monthly rate is published, and the denominator is indeterminate by the seller's own wording: "now only $1249 (from $1599) — 6 to 8 month supply at starting dose". Six months makes that $208 a month and eight makes it $156, and nothing published narrows the range · the "as low as $156/month" printed beside it is that division at its most flattering end and is offered as a payment plan — "flexible payment plans available" — rather than as a rate · ★ the supply length is explicitly tied to the dose, so holding the starting dose is what produces the longer end of the range and a higher dose exhausts the same charge sooner · no molecule is named anywhere on the page: the product is "GLP-1 Management", the FAQ answers are about "peptide therapies", and the only named drugmakers appear in a disclaimer saying the company is not associated with them · the plan is stated to include the provider consult, the compounded prescription and delivery, with no membership and no insurance required
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Quotes off the lowest dose
States plainly that its advertised figures are based on the lowest dosage and that higher doses may cost more. On a general ranking that is a warning; for someone staying small it is the one model that bills accordingly.
36 of the 373 programs we track price a small dose this way. ★ The supply length is tied openly to the dose, which is the one structure where taking less buys more time instead of wasting drug — the seller says the block lasts six to eight months at the starting dose, and a higher dose exhausts the same charge sooner. That range is also the problem: the same money works out about a third dearer per month at the short end than at the long one, and nothing published narrows it, so no monthly rate exists to read. The per-month figure printed beside the block is that division at its most flattering end and is offered as a payment plan rather than a rate. No molecule is named anywhere on the page.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- The supply length is tied openly to the dose, so holding low genuinely stretches the charge.
- One charge covers the consult, the prescription and delivery, with no membership beside it.
- The pre-discount figure is stated alongside the current one rather than left implied.
Pharmacy, labs and oversight
Injectco does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What Injectco publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The pricing here is a single charge for a block of medication, and the block does not have a fixed length. The seller says the supply runs six to eight months at the starting dose, which spreads the same money across a range wide enough that the monthly cost differs by a third depending on which end holds. That is not evasive so much as honest about something most sellers hide: a vial lasts as long as the dose lets it, and a company selling by the vial rather than by the month cannot promise a monthly figure without knowing what you will take. For this site's reader that structure is unusually favorable, because it is the only arrangement in which taking less genuinely buys more time rather than simply wasting drug. Someone holding the starting dose reaches the long end of the range; someone titrating upward reaches the short end. The number to be careful with is the one printed beside the block price. A hundred and fifty-six dollars a month is the block divided by the most optimistic supply length, and the page presents it as a payment plan, which is a financing arrangement rather than a rate for medication. Anyone budgeting from it is assuming the best case on a range the seller declines to narrow. The larger gap is that no drug is named at any point. The product is described by its class, the questions and answers discuss peptide therapy in general, and the only manufacturers mentioned appear in a disclaimer distancing the company from them.
The honest cons
The supply is quoted as a six-to-eight-month range, so the monthly cost differs by a third.
- The per-month figure beside it is a payment plan built on the most optimistic end of that range.
- No molecule is named anywhere, so what the charge buys is described only by drug class.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Injectco is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#234 of 373
Ordered with the companies that pay us first, and Injectco is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- Titrating up from a microdose
- The true annual cost of a plan
- Vial waste calculator
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Elara MD
$249/mo at 0.2 mg/wk semaglutide
- Vs median
- $80/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Quotes off the lowest dose
- Dispensed
- Compounded, 503A pharmacy
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Elara MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.